CN104013734A - Traditional Chinese medicine oral liquid for treating osteoarthritis - Google Patents

Traditional Chinese medicine oral liquid for treating osteoarthritis Download PDF

Info

Publication number
CN104013734A
CN104013734A CN201410278901.7A CN201410278901A CN104013734A CN 104013734 A CN104013734 A CN 104013734A CN 201410278901 A CN201410278901 A CN 201410278901A CN 104013734 A CN104013734 A CN 104013734A
Authority
CN
China
Prior art keywords
grams
chinese medicine
radix
oral liquid
medicine oral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410278901.7A
Other languages
Chinese (zh)
Inventor
徐显廷
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201410278901.7A priority Critical patent/CN104013734A/en
Publication of CN104013734A publication Critical patent/CN104013734A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a traditional Chinese medicine oral liquid for treating osteoarthritis. The traditional Chinese medicine oral liquid is prepared from the following raw materials: 25g of astragalus membranaceus, 20g of cassia twig, 15g of eucommia ulmoides, 15g of radix achyranthis bidentatae, 15g of radix paeoniae alba, 15g of ligusticum wallichii, 15g of pawpaw, 15g of radix angelicae pubescentis, 15g of fructus lycii, 10g of teasel root, 10g of poria cocos, 10g of asarum, 5g of bighead atractylodes rhizome and 5g of saposhnicovia divaricate. The traditional Chinese medicine oral liquid has remarkable curative effect on treating osteoarthritis, is convenient for a patient to take, and has the advantages of stable curative effect, no toxic and side effects and the like.

Description

A kind of Chinese medicine oral liquid for the treatment of osteoarthritis
Technical field
The present invention relates to Chinese medicine, be specifically related to a kind of Chinese medicine oral liquid for the treatment of osteoarthritis.
Background technology
Osteoarthritis claims again degenerative osteoarthritis, and not inflammation has a degenerative change particularly articular cartilage is aging and causes, and claims again senile arthritis.In the crowd that primary disease mostly occurred more than 50 years old.Early stage arthralgia is many to be occurred in the time rising morning, movable rear pain relief; After activity, there is afterwards pain.Sometimes occur arthroncus, often occur in knee joint, elbow joint place, there are obvious tenderness, ankylosis in part.Doctor trained in Western medicine adopts anti-inflammatory agent treatment more, and life-time service is very large to human body side effect.The traditional Chinese medical science thinks that primary disease belongs to rheumatism involving the bone, and deficiency of the liver and kidney is common, takes clinically the method treatment of expelling wind and activating blood circulation, strong muscles and bones.
Summary of the invention
Technical problem to be solved by this invention is to provide a kind of Chinese medicine oral liquid for the treatment of osteoarthritis, and its treatment osteoarthritis therapeutic effect is good, safe and reliable, has no side effect, and therapeutic modality is simple, with low cost.
For solving the problems of the technologies described above, the Chinese medicine oral liquid for the treatment of osteoarthritis of the present invention is to be made up of following bulk drugs: 25 grams of the Radixs Astragali, 20 grams of Ramulus Cinnamomi, 15 grams of the Cortexs Eucommiae, 15 grams of Radix Achyranthis Bidentataes, 15 grams of the Radix Paeoniae Albas, 15 grams of Rhizoma Chuanxiongs, 15 grams of Fructus Chaenomeliss, 15 grams of Radix Angelicae Pubescentiss, 15 grams of Fructus Lycii, 10 grams of Radix Dipsacis, 10 grams, Poria, 10 grams of Herba Asaris, 5 grams of the Rhizoma Atractylodis Macrocephalaes, 5 grams of Radix Saposhnikoviaes.
The preparation method for the treatment of the Chinese medicine oral liquid of osteoarthritis is: get every crude drug, decoct with water 45 ~ 60 minutes, filter to obtain decocting liquid, then decoct with water 45 ~ 60 minutes in medicinal residues, filter to obtain decocting liquid; Merge the decocting liquid of twice, being concentrated into relative density is 1.1 ~ 1.3, to obtain final product.
Medicine of the present invention is to select the Radix Astragali, Ramulus Cinnamomi, the Cortex Eucommiae, Radix Achyranthis Bidentatae, the Radix Paeoniae Alba, Rhizoma Chuanxiong, Fructus Chaenomelis, Radix Angelicae Pubescentis, Fructus Lycii, Radix Dipsaci, Poria, Herba Asari, the Rhizoma Atractylodis Macrocephalae, Radix Saposhnikoviae medicine to combine preparation, make each efficacy of drugs produce synergism these drug regimens, thereby can effectively treat osteoarthritis.The wherein Radix Astragali (tonify deficiency), Ramulus Cinnamomi (complement sun, promoting blood circulation, warming the spleen and stomach), the Cortex Eucommiae (invigorating the liver and kidney, bone and muscle strengthening), Radix Achyranthis Bidentatae (eliminating blood stasis and inducing menstruation, invigorating the liver and kidney, bone and muscle strengthening), the Radix Paeoniae Alba (blood-supplementing blood-nourishing, suppressing liver-YANG, easing the affected liver to relieve pain), Rhizoma Chuanxiong (dispels the wind, removing obstruction in the collateral to relieve pain), Fructus Chaenomelis (cures mainly numbness of the skin, arthralgia), Radix Angelicae Pubescentis (expelling wind and dampness, dispersing cold for relieving pain), Fructus Lycii (cures mainly nourishing the liver and kidney, replenishing vital essence to improve eyesight), Radix Dipsaci (invigorating the liver and kidney, reuniting the fractured tendons and bones, blood circulation regulating), Poria (invigorating middle warmer spleen invigorating), (Herba Asari induces sweat cold expelling, wind-expelling pain-stopping), the Rhizoma Atractylodis Macrocephalae (spleen reinforcing, stomach reinforcing, dampness, with in), Radix Saposhnikoviae (removing dampness to relieve pain, spasmolytic, antipruritic).
The cure rate 80% of Chinese medicine oral liquid treatment osteoarthritis of the present invention, effective percentage 12%, total effective rate 92%.There is determined curative effect, the feature that easy to use, toxic and side effects is little.
Detailed description of the invention
5 grams of 25 grams of the Radixs Astragali, 20 grams of Ramulus Cinnamomi, 15 grams of the Cortexs Eucommiae, 15 grams of Radix Achyranthis Bidentataes, 15 grams of the Radix Paeoniae Albas, 15 grams of Rhizoma Chuanxiongs, 15 grams of Fructus Chaenomeliss, 15 grams of Radix Angelicae Pubescentiss, 15 grams of Fructus Lycii, 10 grams of Radix Dipsacis, 10 grams, Poria, 10 grams of Herba Asaris, 5 grams of the Rhizoma Atractylodis Macrocephalaes, Radix Saposhnikoviae are put into water to be decocted 45 ~ 60 minutes, filter to obtain decocting liquid, in medicinal residues, decoct with water 45 ~ 60 minutes again, filter to obtain decocting liquid; Merge the decocting liquid of twice, being concentrated into relative density is 1.1 ~ 1.3, obtains oral liquid of the present invention.
The usage of oral liquid of the present invention: every day 2 times, each serving using 35ml.It within 40 days, is a course for the treatment of.
The criterion of therapeutical effect of oral liquid of the present invention adopts national Chinese medicine industry standard, specific as follows:
Cure: arthroncus, stiff, part have the symptoms such as obvious tenderness to disappear completely, and the activity of waist knee joint freely, after activity, without any discomfort, can look into without positive sign by whole body.Take a turn for the better: transference cure, ankylosis slightly after fatigue, there is tenderness in local time, and giggle monkey symptom is improved.Invalid: symptom is without any improvement, before treatment.
Oral liquid cure rate 80% of the present invention, effective percentage 12%, total effective rate 92%.Effective percentage is shown in curative effect table.

Claims (2)

1. a Chinese medicine oral liquid for the treatment of osteoarthritis, is characterized in that: be to be made up of following bulk drugs: 25 grams of the Radixs Astragali, 20 grams of Ramulus Cinnamomi, 15 grams of the Cortexs Eucommiae, 15 grams of Radix Achyranthis Bidentataes, 15 grams of the Radix Paeoniae Albas, 15 grams of Rhizoma Chuanxiongs, 15 grams of Fructus Chaenomeliss, 15 grams of Radix Angelicae Pubescentiss, 15 grams of Fructus Lycii, 10 grams of Radix Dipsacis, 10 grams, Poria, 10 grams of Herba Asaris, 5 grams of the Rhizoma Atractylodis Macrocephalaes, 5 grams of Radix Saposhnikoviaes.
2. the preparation method of a kind of Chinese medicine oral liquid for the treatment of osteoarthritis claimed in claim 1, is characterized in that: get every crude drug, decoct with water 45 ~ 60 minutes, filter to obtain decocting liquid, then decoct with water 45 ~ 60 minutes in medicinal residues, filter to obtain decocting liquid; Merge the decocting liquid of twice, being concentrated into relative density is 1.1 ~ 1.3, to obtain final product.
CN201410278901.7A 2014-06-21 2014-06-21 Traditional Chinese medicine oral liquid for treating osteoarthritis Pending CN104013734A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410278901.7A CN104013734A (en) 2014-06-21 2014-06-21 Traditional Chinese medicine oral liquid for treating osteoarthritis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410278901.7A CN104013734A (en) 2014-06-21 2014-06-21 Traditional Chinese medicine oral liquid for treating osteoarthritis

Publications (1)

Publication Number Publication Date
CN104013734A true CN104013734A (en) 2014-09-03

Family

ID=51430917

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410278901.7A Pending CN104013734A (en) 2014-06-21 2014-06-21 Traditional Chinese medicine oral liquid for treating osteoarthritis

Country Status (1)

Country Link
CN (1) CN104013734A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105770251A (en) * 2014-12-26 2016-07-20 房县中医院 Tongning capsule for treatment of cervical spondylosis, lumbar diseases and arthritis
EP3117834A1 (en) * 2015-07-14 2017-01-18 Infinitus (China) Company Ltd. A bone and joint protection composition and use thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
朱卫星等: "五联疗法治疗膝关节骨性关节炎538例", 《中医外治杂志》 *
王福林等: "中医分型辨治配合综合治疗骨性关节炎的临床研究", 《甘肃省中医药学会2008年学术论文集》 *
郭敏: "三痹汤配合针刺疗法治疗膝关节骨性关节炎30例临床观察", 《中医临床研究》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105770251A (en) * 2014-12-26 2016-07-20 房县中医院 Tongning capsule for treatment of cervical spondylosis, lumbar diseases and arthritis
EP3117834A1 (en) * 2015-07-14 2017-01-18 Infinitus (China) Company Ltd. A bone and joint protection composition and use thereof

Similar Documents

Publication Publication Date Title
CN102670979B (en) Osteopathic medicinal wine for treating rheumatism and preparation process thereof
CN103349753B (en) Traditional Chinese medicine composition for treating kidney deficiency
CN103393840A (en) Traditional Chinese medicine composition for treating osteoarthritis
CN102327380A (en) Chinese medicinal composition for treating knee osteoarthritis
CN102008655B (en) Traditional Chinese medicine composition for treating arthralgia and preparation method thereof
CN103784887A (en) Traditional Chinese medicinal composition for treating kidney deficiency lumbago
CN101181449A (en) Medicine liqueur for curing osteoproliferation
CN102600345B (en) Traditional Chinese medicine for treating rheumatic lumbocrural pain
CN104000933A (en) Traditional Chinese medicine oral liquid for treating osteoproliferation
CN102475868A (en) Anti-rheumatism medicinal liquor
CN104013769A (en) Traditional Chinese medicine oral solution for treating osteoporosis
CN106266896A (en) A kind of invigorating primordial QI, kidney invigorating and YANG supporting, bone and muscle strengthening, the pill of curing rheumatism
CN105477519A (en) Rheumatism arthralgia treating traditional Chinese medicine
CN103446360B (en) Traditional Chinese medicine capsule preparation for treating lumbar disc herniation and preparation method of traditional Chinese medicine capsule preparation
CN104013734A (en) Traditional Chinese medicine oral liquid for treating osteoarthritis
CN100490880C (en) Chinese medicinal composition for treating rheumatic and rheumatoid arthritis
CN103800840A (en) Oral traditional Chinese medicine solution for treating cervical spondylosis
CN104547117A (en) Traditional Chinese medicine preparation for treating gonarthromeningitis
CN104013939A (en) Traditional Chinese medicine oral solution for treating scapulohumeral periarthritis
CN101411799B (en) Oral medicinal liquor for treating rheumatism and rheumatoid disease
CN102512543B (en) Chinese medicinal composition for treating rheumatoid arthritis
CN102512560A (en) Traditional Chinese medicinal composition for treating arthromyodynia
CN103169876B (en) Chinese medicament composition for treating arthralgia
CN101361888B (en) Traditional Chinese medicine for treating rheumatism and rheumatoid
CN105169279A (en) Traditional Chinese medicine composition for treating knee joint bone hyperplasia

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20140903